Massive haemothorax: a very rare complication of pulmonary embolism thrombolysis
DOI:
https://doi.org/10.32818/reccmi.a2n1a13Keywords:
massive haemothorax, pulmonary embolism, thrombolysisAbstract
Massive haemothorax secondary to thrombolysis during the treatment of pulmonary embolism (PE) is an exceptional and poorly documented in the literature event. We talk about massive haemothorax when the amount of extravasated fluid in pleura exceeds 1,500 mL, which is a serious haemodynamic compromise. Spontaneous haemothorax is a rare entity whose most common causes are ruptured arteriovenous malformations, tumors, coagulation disorders or secondary to anticoagulant therapy. We present a case of massive spontaneous haemothorax secondary to systemic thrombolytic treatment in a patient with pulmonary embolism.
Downloads
Metrics
References
Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2008; 29: 2276- 2315.
Varnholt V, Ringe H, Nietsch L, et al. Hemothorax under thrombolytic therapy with recombinant tissue: plasminogen activator (rt-PA) in a 16-year-old girl. Eur J Pediatr. 1999; 158(Suppl 3): S140-142.
Ryan CA, Andrew M. Failure of thrombolytic therapy in four children with extensive thromboses. AJDC. 1992; 146: 187-193.
Wick MR, Ritter JH, Schuller D. Ruptured pulmonary infarction: a rare, fatal complication of thromboembolic disease. Mayo Clin Proc. 2000; 75(6): 639-642.
Ali HA, Lippmann M, Mundathaje U, et al. Spontaneous hemothorax: a comprehensive review. Chest. 2008; 134: 1056-1065.
Wang CC, Ng CJ, Seak CK, Seak CJ. Spontaneous hemothorax following thrombolytic and anticoagulant therapy for massive pulmonary embolism. Am J Emerg Med. 2013; 31: 999.e1-3.
Kelmenson DA, Kurche JS, Geraci M. Spontaneous hemothorax resulting from tissue plasminogen activator in a patient with ischemic stroke and unrecognized recent myocardial infarction. Annals of the American Thoracic Society. 2015; 12: 1105-1106.
Varnholt V, Ringe H, Nietsch L, Gaedicke G. Hemothorax under thrombolytic therapy with recombinant tissue: plasminogen activator (Rt-PA) in a 16-year-old girl. Eur J Pediatr. 1999; 158: S140-142.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Vladimir Rosa-Salazar, Andrea Cayuela-López, Esperanza Marín-Arranz, Bartolomé García-Pérez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
